06.03.13
Patheon
2Q Revenues: $253.9 million (+40%)
2Q Earnings: $0.1 million (loss of $79.7 million 2Q12)
YTD Revenues: $467.4 million (+39%)
YTD Loss: $51.3 million (loss of $99.0 million YTD12)
Comments: CMO revenues were $219.5 million in the quarter, up 49%. Pharmaceutical Development Services (PDS) revenues were flat at $34.4 million, reflecting the impact of the sale of Patheon's clinical packaging business to Bellwyck Packaging Solutions in fiscal 2012. The recent acquisition of Banner Pharmacaps contributed $54.6 million in the quarter, while Patheon’s non-Banner revenues grew 10%.
2Q Revenues: $253.9 million (+40%)
2Q Earnings: $0.1 million (loss of $79.7 million 2Q12)
YTD Revenues: $467.4 million (+39%)
YTD Loss: $51.3 million (loss of $99.0 million YTD12)
Comments: CMO revenues were $219.5 million in the quarter, up 49%. Pharmaceutical Development Services (PDS) revenues were flat at $34.4 million, reflecting the impact of the sale of Patheon's clinical packaging business to Bellwyck Packaging Solutions in fiscal 2012. The recent acquisition of Banner Pharmacaps contributed $54.6 million in the quarter, while Patheon’s non-Banner revenues grew 10%.